New blood test to detect colon cancer clears FDA approval
- A new blood test aimed at helping doctors diagnose colorectal cancer - the second-leading cause of U.
- cancer deaths - was recently approved by the Food and Drug Administration.
- SimpleScreen, made by the California biotech company Freenome, is designed for adults aged 45 and older who are at average risk for the life-threatening disease.
Unverified
- A new blood test aimed at helping doctors diagnose colorectal cancer - the second-leading cause of U.
- cancer deaths - was recently approved by the Food and Drug Administration.
- SimpleScreen, made by the California biotech company Freenome, is designed for adults aged 45 and older who are at average risk for the life-threatening disease.
Sources: The Independent